Recommendation ID
CG173/3
Question

What is the clinical and cost effectiveness of carbamazepine as initial treatment for trigeminal neuralgia compared with other pharmacological treatments?

Any explanatory notes
(if applicable)

Carbamazepine has been the standard treatment for trigeminal neuralgia since the 1960s. Despite the lack of trial evidence, it is perceived by clinicians to be efficacious.


Source guidance details

Comes from guidance
Neuropathic pain in adults: pharmacological management in non-specialist settings
Number
CG173
Date issued
November 2013

Other details

Is this a recommendation for the use of a technology only in the context of research? No  
Is it a recommendation that suggests collection of data or the establishment of a register?   No  
Last Reviewed 01/09/2020